A few days ago, the headlines blared that a federally appointed Task Force of doctors and scientists recommended that the age for using mammography as a screening tool to detect breast cancer be increased from the current 40-49 years to 50-59 years, be dispensed with for those older than 75 and be biannual for those in the suggested age range for screening, rather than annual, also that breast self-exam teaching to women was essentially useless and generated more anxiety than results.
A furore erupted. The American Cancer Society and almost all major medical bodies vehemently attacked these recommendations as being unwarranted, given that the screening for women aged 40-49 has saved many lives. The emotional/familial cost benefit of a life saved vs. a thousand more women subjected to 'anxiety from needless tests' was vastly more than the corresponding economic cost benefit.
These recommendations are what happen when the cold realities of models and benefits of screenings vs. lives saved are weighed as the major factor in deciding public policy.
Among the studies quoted by the task force:
JAMA- "Rethinking screening for Breast and Prostate Cancer"
"After 20 years of screening for breast and prostate cancer, several observations can be made. First, the incidence of these cancers increased after the introduction of screening but has never returned to prescreening levels. Second, the increase in the relative fraction of early stage cancers has increased. Third, the incidence of regional cancers has not decreased at a commensurate rate. One possible explanation is that screening may be increasing the burden of low-risk cancers without significantly reducing the burden of more aggressively growing cancers and therefore not resulting in the anticipated reduction in cancer mortality. To reduce morbidity and mortality from prostate cancer and breast cancer, new approaches for screening, early detection, and prevention for both diseases should be considered."
"SEER Incidence
From 2002-2006, the median age at diagnosis for cancer of the breast was 61 years of age3.
Approximately 0.0% were diagnosed under age 20; 1.9% between 20 and 34;
10.5% between 35 and 44; 22.5% between 45 and 54; 23.7% between 55 and
64; 19.6% between 65 and 74; 16.2% between 75 and 84; and 5.5% 85+
years of age."
Compared with say, lung cancer, the number of women per 100,000 who die of lung cancer is approximately 40, as opposed to 24 in 100,000 due to breast cancer, from the SEER website. So breast cancer is not the number-one killer cancer of women, though with all the pink ribbons, we might think that it is the most deadly cancer for women in the US.
So, the good doctors assembled and came to the conclusion that pushing for early screenings for a cancer that is deadlier in an older age group is nonsensical, and that it causes unnecessary scaremongering for younger women who aren't quite as likely to die of breast cancer. Hence the recommendations.
But here's when the intersection occurs of 'One life saved is worth it' and emotional appeals from 100,000 women freshly diagnosed with ductal carcinoma in situ at the age of 40 or thereabouts, followed by chemotherapy regimens designed to kill those and label all of them as breast cancer survivors who proudly wear pink ribbons to announce their status, even as they muster courage to fight on, while death is held at bay through expensive medication to prevent recurrence. The argument moves from the numbers and public health policy decisions to that of emotional appeals.
As for me, maybe I'll take the middle way out, given that I live in a much more xenoestrogenic environment in the US, as opposed to where I was born and brought up. I'll mammo after another 4-5 years, rather than immediately.
As for Pap smears, there appears to be no hue and cry over the new recommendations by the physicians' body for OB-Gynes, so I'll take their word for it and postpone those uncomfortable tests to match their new suggested schedule.
"Dr. Iglesia said the argument for changing Pap screening was more
compelling than that for cutting back on mammography — which the
obstetricians’ group has staunchly opposed — because there is more
potential for harm from the overuse of Pap tests. The reason is that
young women are especially prone to develop abnormalities in the cervix
that appear to be precancerous, but that will go away if left alone.
But when Pap tests find the growths, doctors often remove them, with
procedures that can injure the cervix and lead to problems later when a
woman becomes pregnant, including premature birth and an increased risk
of needing a Caesarean."
Leave a reply to Ruchira Cancel reply